Published in Dtsch Z Verdau Stoffwechselkr on January 01, 1981
The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA (1991) 5.84
A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol (1995) 3.35
Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology (1998) 1.84
[The taxonomic problem of Clostridium sordellii and Clostridium bifermentans]. Med Dosw Mikrobiol (1966) 1.72
Indigenous hepatitis E virus infection of a plasma donor in Germany. Vox Sang (2009) 1.60
Active syphilis in HIV infection: a multicentre retrospective survey. The German AIDS Study Group (GASG). Genitourin Med (1996) 1.58
Recombination in Tula hantavirus evolution: analysis of genetic lineages from Slovakia. J Virol (1999) 1.54
Dobrava hantavirus causes hemorrhagic fever with renal syndrome in central Europe and is carried by two different Apodemus mice species. J Med Virol (2001) 1.42
Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut (2009) 1.40
Seroprevalence of hantavirus antibodies in Germany as determined by a new recombinant enzyme immunoassay. Eur J Clin Microbiol Infect Dis (1995) 1.28
Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br J Nutr (2000) 1.22
Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease. J Virol (1996) 1.21
Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus. Hepatology (1997) 1.20
Risk factors for the development of lithium-induced polyuria. Br J Psychiatry (2003) 1.19
Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus. J Virol (1997) 1.17
Core particles of hepatitis B virus as carrier for foreign epitopes. Adv Virus Res (1998) 1.17
Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment. Virology (1992) 1.15
Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998. Eur J Epidemiol (2001) 1.14
Short report: simultaneous occurrence of Dobrava, Puumala, and Tula Hantaviruses in Slovakia. Am J Trop Med Hyg (1999) 1.11
Concurrent expression of erythroid and renal aquaporin CHIP and appearance of water channel activity in perinatal rats. J Clin Invest (1993) 1.06
Human cytomegalovirus (HCMV) encephalitis in an immunocompetent young person and diagnostic reliability of HCMV DNA PCR using cerebrospinal fluid of nonimmunosuppressed patients. J Clin Microbiol (1998) 1.05
Imaging the penumbra - strategies to detect tissue at risk after ischemic stroke. J Clin Neurosci (2008) 1.04
Clinical characterization of Dobrava hantavirus infections in Germany. Clin Nephrol (2001) 1.04
Genetic characterization of a new hantavirus detected in Microtus arvalis from Slovakia. Virus Genes (1995) 0.95
Accumulation and persistence of hepatitis B virus core gene deletion mutants in renal transplant patients are associated with end-stage liver disease. Hepatology (1996) 0.94
Longitudinal prevalence and determinants of early mood disorder post-stroke. J Clin Neurosci (2007) 0.94
Cross-linking of phospholipids to proteins in the erythrocyte membrane. Biochem Biophys Res Commun (1973) 0.94
Heterogeneity of hepatitis B virus C-gene sequences: implications for amplification and sequencing. J Hepatol (1993) 0.94
Identification of a novel angiotensin-I-converting enzyme inhibitory peptide corresponding to a tryptic fragment of bovine beta-lactoglobulin. FEBS Lett (1997) 0.94
Distribution of hepatitis C virus genotypes in German patients with chronic hepatitis C: correlation with clinical and virological parameters. J Hepatol (1997) 0.94
Life-threatening Dobrava hantavirus infection with unusually extended pulmonary involvement. Clin Nephrol (2004) 0.93
Bioactive peptides derived from milk proteins. Structural, physiological and analytical aspects. Nahrung (1995) 0.93
Hepatitis C virus (HCV) genotype distribution in German isolates: studies on the sequence variability in the E2 and NS5 region. Arch Virol (1994) 0.92
Nucleosides and nucleotides: natural bioactive substances in milk and colostrum. Br J Nutr (2000) 0.91
The fate of hypoxic tissue on 18F-fluoromisonidazole positron emission tomography after ischemic stroke. Ann Neurol (2000) 0.91
Stimulation of human peripheral blood lymphocytes by bioactive peptides derived from bovine milk proteins. FEBS Lett (1996) 0.90
Mapping of immunodominant B-cell epitopes and the human serum albumin-binding site in natural hepatitis B virus surface antigen of defined genosubtype. J Gen Virol (2000) 0.90
Human red cell Aquaporin CHIP. II. Expression during normal fetal development and in a novel form of congenital dyserythropoietic anemia. J Clin Invest (1994) 0.90
Detection of human hantavirus infections in Lithuania. Infection (2005) 0.90
Baseline blood pressure but not early computed tomography changes predicts major hemorrhage after streptokinase in acute ischemic stroke. Stroke (2002) 0.90
Percutaneous ultrasound-guided renal biopsy: A Libyan experience. Indian J Nephrol (2010) 0.90
Chimaeric HBV core particles carrying a defined segment of Puumala hantavirus nucleocapsid protein evoke protective immunity in an animal model. Vaccine (1998) 0.90
[Prevalence of hantavirus infections in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2004) 0.90
Comparative inhibition of hepatitis B virus DNA polymerase and cellular DNA polymerases by triphosphates of sugar-modified 5-methyldeoxycytidines and of other nucleoside analogs. Antimicrob Agents Chemother (1991) 0.88
Coding strategy of the S and M genomic segments of a hantavirus representing a new subtype of the Puumala serotype. Arch Virol (1995) 0.88
Mapping of B-cell epitopes in the nucleocapsid protein of Puumala hantavirus. Viral Immunol (2002) 0.88
Nasal airway volumetric measurement using segmented HRCT images and acoustic rhinometry. Am J Rhinol (1999) 0.88
Rational use of diagnostic tools in hepatitis C. J Hepatol (1996) 0.87
Lactokinins: whey protein-derived ACE inhibitory peptides. Nahrung (1999) 0.86
New chimaeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: immunogenicity and protection against virus challenge. J Biotechnol (1999) 0.86
HBV core particles allow the insertion and surface exposure of the entire potentially protective region of Puumala hantavirus nucleocapsid protein. Biol Chem (1999) 0.86
Successful outcome with aggressive treatment of acute haemorrhagic leukoencephalitis. J Neurol Neurosurg Psychiatry (1997) 0.85
Transmission of GBV-C/HGV from drug-addicted mothers to their babies. J Hepatol (1997) 0.85
Hepatitis B virus genomes from long-term immunosuppressed virus carriers are modified by specific mutations in several regions. J Gen Virol (1999) 0.85
Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity. Virology (1998) 0.85
HIV-1 peripheral neuropathy and combination antiretroviral therapy. Lancet (1998) 0.84
Cross-linking of phospholipid neighbors in the erythrocyte membrane. Biochem Biophys Res Commun (1974) 0.84
Immunodominant B-cell domains of hepatitis C virus envelope proteins E1 and E2 identified during early and late time points of infection. J Hepatol (1999) 0.83
Antibodies directed to envelope proteins of hepatitis C virus outside of hypervariable region 1. Virology (1998) 0.83
Automated bed to aid pulmonary drainage and prevent decubitus ulcers. Med Biol Eng (1975) 0.82
Caseinophosphopeptides and their cell modulating potential. Biofactors (2004) 0.82
Chemical characterization and opioid activity of an exorphin isolated from in vivo digests of casein. FEBS Lett (1986) 0.82
Treatment of chronic hepatitis B with interferon alfa-2b. J Hepatol (1990) 0.82
Primary hepatic or splenic diffuse large B-cell lymphoma and hepatitis C virus infection: a non-fortuitous association? Ann Hematol (2000) 0.82
First molecular evidence for Puumala hantavirus in Slovakia. Virus Genes (2001) 0.81
Puumala (PUU) hantavirus strain differences and insertion positions in the hepatitis B virus core antigen influence B-cell immunogenicity and protective potential of core-derived particles. Virology (2000) 0.81
When it's not ringworm: annular lesions of childhood. Pediatr Ann (1998) 0.81
[Prevalence of antibodies to hepatitis A, hepatitis B and hepatitis C viruses in the German population]. Gesundheitswesen (1999) 0.80
Patterns of mycobacterium avium culture and PCR positivity in immunodeficient HIV-infected patients: progression from localized to systematic disease, German Aids Study Group (GASG/IDKF). Scand J Infect Dis (1997) 0.80
Leg load warning system for the orthopaedically handicapped. Med Biol Eng (1974) 0.80
Expression, assembly competence and antigenic properties of hepatitis B virus core gene deletion variants from infected liver cells. J Gen Virol (1999) 0.80
DNA vaccination of mice with a plasmid encoding Puumala hantavirus nucleocapsid protein mimics the B-cell response induced by virus infection. J Biotechnol (2001) 0.80
Sensory ataxia in myelopathy with chronic hepatitis C virus infection. Neurology (2002) 0.80
Synthetic peptides corresponding to alpha-lactalbumin and beta-lactoglobulin sequences with angiotensin-I-converting enzyme inhibitory activity. Biol Chem Hoppe Seyler (1996) 0.79
Characterization of potential insertion sites in the core antigen of hepatitis B virus by the use of a short-sized model epitope. Intervirology (1999) 0.79
[Rational diagnosis of functional hyperbilirubinemia and management of patients with Gilbert-Meulengracht syndrome]. Dtsch Z Verdau Stoffwechselkr (1987) 0.78
Mosaic hepatitis B virus core particles allow insertion of extended foreign protein segments. J Gen Virol (1997) 0.78
Warning device for the prevention of ischaemic ulcers in quadriplegics. Med Biol Eng (1976) 0.77
Interaction of wild-type and naturally occurring deleted variants of hepatitis B virus core polypeptides leads to formation of mosaic particles. FEBS Lett (2000) 0.77
Low dose alpha interferon treatment in chronic hepatitis B virus infection. Gut (1993) 0.76
Parvovirus B19 infection associated with unilateral cervical lymphadenopathy, apoptotic sinus histiocytosis, and prolonged fatigue. J Clin Pathol (2005) 0.76
Muramyl dipeptide does not induce slow-wave sleep or fever in rats. Peptides (1984) 0.76
A new variant of progressive encephalomyelitis with rigidity associated with cerebellar ataxia and dementia: correlation of MRI and histopathological changes. A case report. Neurol Res (1997) 0.76
Post-translational phosphorylation affects the IgE binding capacity of caseins. FEBS Lett (2000) 0.76
Copulatory stimuli in rats induce heat abbreviation through effects on genitalia but not through effects on central nervous mechanisms supporting the steroid hormone-induced sexual responsiveness. Behav Brain Res (1992) 0.76
Treatment of chronic hepatitis B with interferon alpha-2b and interleukin-2. J Hepatol (1993) 0.76
[Treatment of chronic hepatitis B with interferon alpha-2b]. Gastroenterol J (1990) 0.76
Effects of treatment of male and female rats in infancy with mifepristone on reproductive function in adulthood. J Reprod Fertil (1990) 0.76
Reticuloendothelial phagocytosis of Cr 51 -labeled sheep red cells in mice. I. Assay employing total body counting. Isr J Med Sci (1972) 0.76